Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,323 recruiting studies in this area right now.
By phase
- Not applicable4,388
- Phase 2609
- Phase 1412
- Phase 3321
- Phase 4269
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer338
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer190
- Acute Kidney Injury136
- Endometriosis135
- Pregnancy132
- Chronic Kidney Diseases131
- Breast Cancer107
- Chronic Kidney Disease104
- Infertility94
- Renal Cell Carcinoma80
- Colorectal Cancer74
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Pregnancy Complications63
- Urinary Incontinence63
Leading sponsors
- Mayo Clinic58
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS48
- Assistance Publique - Hôpitaux de Paris47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)40
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca34
Where studies are running
- California345
- Alabama155
- Texas121
- Massachusetts119
- New York118
- Florida103
- Arizona100
- Colorado90
- Maryland90
- Illinois78
Recruiting studies6,323 total
- NCT07702318Enrolling by invitation
Early childhood outcomes in former very low birth weight babies
This study follows children who were part of the ReDiMOM trial to check their development and growth at 2 years old. It helps doctors understand how early care affects long-term health.
Chicago, IllinoisAges Up to 3 years - NCT04606914RecruitingPhase 2
Carboplatin plus mirvetuximab for advanced ovarian cancer after chemo
This Phase 2 study tests adding mirvetuximab to carboplatin for people with advanced, high-grade serous ovarian cancer who will first receive “neoadjuvant” chemotherapy. It is designed for tumors that strongly show FRα, which mirvetuximab targets, to see if this improves outcomes.
Birmingham, AlabamaAges 18 years+ - NCT04494945Recruiting
Help for people with inherited cancer risk genes
This study helps identify people who may have an inherited cancer risk and checks how best to support them. Depending on the group, you may only fill out surveys, or you may also create an app account and possibly provide a DNA sample.
Portland, OregonAges 18 years+ - NCT07698925Recruiting
Breathing exercises for sleep problems in PCOS
This trial tests if simple diaphragmatic breathing exercises can improve sleep for women with Polycystic Ovarian Syndrome (PCOS) who have trouble sleeping. If you have PCOS and poor sleep, this gentle, non-drug approach might help.
Cairo, Cairo GovernorateAges 25–35 - NCT04918186RecruitingPhase 2
Immunotherapy for platinum-resistant ovarian, with tumor testing
This Phase 2 study tests an immunotherapy approach for women whose high-grade serous ovarian cancer came back within 6 months of platinum chemotherapy. It may help shrink tumors and improve control of the disease, but you’ll need tumor biopsies and lab/heart/lung checks to join.
Chicago, IllinoisAges 18 years+ - NCT06954740RecruitingPhase 2
Stem cell treatment for acute kidney injury
This study tests a special type of stem cell treatment called mesenchymal stromal cells (Amimestrocel) for patients with acute kidney injury. The goal is to see if this treatment can help kidneys recover better than standard care.
Beijing, Beijing MunicipalityAges 18–75 - NCT07564232RecruitingPhase 1
LNK001 for Advanced Kidney Cancer After Prior Treatments
This Phase 1 trial tests a new cell therapy called LNK001 in patients with advanced clear-cell kidney cancer that has progressed despite prior immunotherapy and targeted drugs. The therapy is designed to recognize and attack cancer cells by targeting a protein called CAIX.
Houston, TexasAges 18–70 - NCT06516653Recruiting
Study of VasQ implant for new dialysis fistula support
This study tests a small mesh support called VasQ that is placed around your new fistula to help it heal and stay open longer. It is for people who are getting a new fistula for dialysis access.
Long Beach, CaliforniaAges 18–80 - NCT04008147Recruiting
Testing iron-related hormones and sugar levels in mid-pregnancy
This study looks at how the hormone hepcidin and blood sugar/metabolism change during pregnancy, and how they respond to either stopping iron supplements briefly or taking a specific prenatal iron-containing multivitamin. It may help doctors better understand iron balance in pregnancy and how it could affect metabolism.
ZurichAges 18–45 - NCT04008563Recruiting
Weight-loss surgery to protect fertility in early womb cancer
This study tests whether bariatric (weight-loss) surgery can help treat certain early, low-grade womb changes while preserving fertility. It’s mainly for people with a higher BMI who want to have children and have an early stage diagnosis confirmed by scans.
Toronto, OntarioAges 18–41 - NCT04014530RecruitingPhase 1/Phase 2
Testing pembrolizumab plus ataluren for metastatic dMMR or pMMR cancer
This early-phase trial tests pembrolizumab combined with ataluren for people with metastatic colorectal cancer that has either dMMR or pMMR, and for metastatic dMMR endometrial cancer. The goal is to see whether this combination can shrink tumors or improve outcomes for cancers with specific mismatch repair (MMR) features.
Amsterdam, North HollandAges 18 years+ - NCT04016389Recruiting
Neoadjuvant chemo then fertility-sparing surgery for cervical cancer
This study looks at whether giving chemotherapy before surgery (neoadjuvant chemotherapy) can shrink certain cervical cancers enough to allow fertility-sparing surgery. It may help some people avoid removing the uterus, while still treating the cancer effectively.
Houston, TexasAges 18–40 - NCT04020510RecruitingPhase 4
Standard versus fewer bladder Botox injections for overactive bladder
This study compares the usual amount of Botox injected into the bladder versus a smaller amount. It aims to see whether fewer injections can reduce overactive bladder symptoms with fewer side effects, like trouble emptying the bladder.
Bethesda, MarylandAges 18 years+ - NCT04021485Recruiting
Smaller steroid dose test for early-born children’s brain outcomes
This study checks whether giving a lower dose of a steroid medicine (betamethasone) to mothers before birth produces similar brain and thinking outcomes in children born very early (before 32 weeks). It may help reduce medicine exposure while keeping developmental results the same.
Paris, PaAges 5–6 - NCT04033224Recruiting
Blood-filter treatments for ICU patients with kidney and organ failure
This trial tests a specific type of blood-filter treatment in critically ill ICU patients who have acute kidney injury and/or failure of other organs. It aims to see whether these filters can improve care by supporting kidney function and/or calming harmful inflammation.
Empoli, FirenzeAges Any age - NCT04038619RecruitingPhase 1
Fecal transplant for immune-therapy diarrhea or bowel inflammation
This early-phase study tests whether stool/fecal microbiota transplant (a fecal transplant) can help people who develop significant diarrhea or colitis after immune-checkpoint therapy. It aims to reduce bowel inflammation and improve symptoms, while carefully checking for infections.
Houston, TexasAges 18 years+ - NCT04039061Recruiting
Study registry for people with ADPKD
This trial is a patient registry that collects information from people who have—or might have—autosomal dominant polycystic kidney disease (ADPKD). It may help researchers better understand the condition and improve future studies.
Kansas City, MissouriAges Any age - NCT04044963Recruiting
Exercise program before kidney transplant to improve physical strength
This trial tests whether a home exercise program before kidney transplant can improve physical function and strength. If you’re getting a transplant and can safely exercise, you may be able to join the study and help compare outcomes.
Vancouver, British ColumbiaAges 19 years+ - NCT04047849RecruitingPhase 4
Antibiotics for early water breaking before 23 weeks
This trial studies whether taking antibiotics can help in pregnancies where the “water” broke early (before 23 weeks) but you don’t have a fever. It aims to reduce complications while keeping both mother and baby as safe as possible.
Baton Rouge, LouisianaAges 18 years+ - NCT04053478Recruiting
Testing common blood-pressure drugs on uterine and umbilical muscle
This study tests how several medicines used for blood pressure affect muscle “tightening” in tissue taken during planned C-sections. It’s an in-vitro (lab) study, so it mainly helps doctors understand how to prevent weak uterine contractions (uterine atony) during delivery.
Toronto, OntarioAges 19–40 - NCT04055649RecruitingPhase 2
Test of ONC201 and weekly paclitaxel for platinum-resistant ovarian cancer
This Phase 2 study tests whether ONC201 given with weekly paclitaxel can control platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer. It may help by shrinking tumors or slowing growth in people whose cancer has progressed after platinum chemotherapy.
Detroit, MichiganAges 18 years+ - NCT04053855Recruiting
Check urine for kidney cancer signals before or after surgery
This study looks for tiny substances in urine (called exosomes) to see if they can help identify clear cell kidney cancer. It compares urine samples from people having planned kidney surgery with people having surgery without a scheduled plan.
Saint-EtienneAges 18 years+ - NCT04057924Recruiting
Watchful waiting for certain abnormal cells in the cervix
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
BordeauxAges 18 years+ - NCT04061967Recruiting
Reminder and self-sampling to help cervical screening
This study tests whether reminders and providing an at-home sample kit can help more women complete cervical cancer screening. It may help people who have not had follow-up after a prior abnormal result or who haven’t been screened in many years.
Luleå, Norrbotten CountyAges 33–75
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,323 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,263 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.